To include your compound in the COVID-19 Resource Center, submit it here.

ETC-216: Phase II

Researchers published results from a double-blind U.S. Phase II study in 47 patients that completed treatment showing that ETC-216 met

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE